HIV and AIDS Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
This trial has four separate groups (cohorts). A person may be considered for one group depending on their situation.
Group 1 (Clinic patients – new to HIV treatment):
- Adults aged 18 or older
- Attending a participating clinic for HIV diagnosis or care
- Not currently taking HIV treatment, or has been taking it for no more than one month at the time of the next clinic visit
- Has been checked for advanced HIV disease (a serious stage of HIV illness) by the clinic, either before or within one month of starting HIV treatment
- Has given written agreement to take part
Group 2 (Clinic patients – recently started or restarted HIV treatment):
- Adults aged 18 or older
- Living with HIV and has been checked for advanced HIV disease at a participating clinic within 12 months of the study's data collection starting at that site
- Started or restarted HIV treatment within the past 6 months
- Returns to the participating clinic for a visit during the enrollment period
- Meets the same general criteria as Group 1
- Has given written agreement to take part
Group 3 (Hospital inpatients):
- Adults aged 18 or older
- Living with HIV
- Admitted to hospital for care related to advanced HIV disease
- Started or restarted HIV treatment within the last 6 months
- Has given written agreement to take part
Group 4 (Healthcare workers):
- Has worked at or for a participating clinic for at least 6 months
- Directly works with patients who have advanced HIV disease
- Has given written agreement to take part
Who may not be able to join:
Group 1:
- People who are pregnant or attending antenatal (pregnancy) care
- People who are too unwell at the time of the advanced HIV disease check and at the following clinic visit to take part
- People who are not able to communicate in any of the languages the study questionnaire is available in, or that the research assistant speaks
Group 2:
- People who are pregnant or attending antenatal care (as recorded in their medical records)
- People who are too unwell at the time of the study enrollment visit to take part
- People who are not able to communicate in any of the languages the study questionnaire is available in, or that the research assistant speaks
- People who have been on HIV treatment for more than 6 months
Group 3:
- People who are pregnant or attending antenatal care
- People who are not physically, mentally, or emotionally well enough to take part before leaving the hospital, based on the judgment of clinic or study staff
- People who are not able to communicate in any of the languages the study questionnaire is available in, or that the research assistant speaks
- People currently in a tuberculosis isolation ward, intensive care unit, or a ward specifically for patients with serious infectious diseases
Group 4:
- There are no exclusion criteria listed for this group
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Thandiwe Ngoma, CHAI-Zambia
Phone: (857) 207-7909
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Initiation characteristics; Inpatient characteristics; Six-month retention; Six-month viral suppression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.